Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Burkitt Lymphoma 23Multiple Myeloma 21Lymphoma, Large B-Cell, Diffuse 21Leukemia, Myeloid, Acute 18Lymphoma, Non-Hodgkin 16Myelodysplastic Syndromes 15Lymphoma, B-Cell 14Lymphoma 14Recurrence 11Ovarian Neoplasms 11Lymphoma, Follicular 11Hodgkin Disease 11Triple Negative Breast Neoplasms 10Neoplasms 9Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Pancreatic Neoplasms 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia 8Hematologic Neoplasms 7Sarcoma 6Osteosarcoma 6Leukemia, Myelomonocytic, Chronic 6Colorectal Neoplasms 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Graft vs Host Disease 5

Interventions

dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Dexamethasone 2Calcium Dobesilate 2Biopsy 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2venetoclax 1ixazomib 1daratumumab 1belantamab mafodotin 1X-Rays 1Stem Cell Transplantation 1Phantoms, Imaging 1Melphalan 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoglobulin Light-chain Amyloidosis × Cyclophosphamide × 30 days × Clear all
NCT06022939 2026-05-06

Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis

SWOG Cancer Research Network

Phase 3 Recruiting
338 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡